A researcher reflects on progress fighting hepatitis C, and a path forward.
infosurhoy,
When I began my medical career in Hong Kong in the early 1980s, I chose to focus on hepatitis B, in part because it was very…
When I began my medical career in Hong Kong in the early 1980s, I chose to focus on hepatitis B, in part because it was very…
– By Anna Suk-Fong Lok, Professor of Internal Medicine, University of Michigan When I began my medical career in Hong Kong in…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
Anna Suk-Fong Lok, University of Michigan (The Conversation is an independent and nonprofit source of news, analysis and…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
When I began my medical career in Hong Kong in the early 1980s, I chose to focus on hepatitis B, in part because it was very…
When I began my medical career in Hong Kong in the early 1980s, I chose to focus on hepatitis B, in part because it was very…
When I began my medical career in Hong Kong in the early 1980s, I chose to focus on hepatitis B, in part because it was very…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
Text CHRON to 77453 for alerts https://www.chron.com/news/article/The-thrill-of-curing-hepatitis-C-and-the-pain-of-13109956.php…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Anna Suk-Fong…
Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops viral-based immunotherapies, announces that…
Data presented at AASLD Liver Meeting 2017 Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops…
STRASBOURG, France --(BUSINESS WIRE)-- Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops viral…
Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops viral-based immunotherapies, announces that…
STRASBOURG, France--(Business Wire)--Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops viral-ba…
Data presented at AASLD Liver Meeting 2017 Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops…
STRASBOURG, France--( BUSINESS WIRE )--Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops viral…
Data presented at AASLD Liver Meeting 2017 STRASBOURG, France--(BUSINESS WIRE)-- Regulatory News: Transgene (Paris: TNG ), a…
envelop protein – HbsAg) have been shown in the patients who received the two highest doses (1010 vp et 1011 vp); A dose-effect…
Data Featured in a Poster Presentation at AASLD Liver Meeting 2017 Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG)…
STRASBOURG, France--(Business Wire)--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that…
Data Featured in a Poster Presentation at AASLD Liver Meeting 2017 Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG)…
Data Featured in a Poster Presentation at AASLD Liver Meeting 2017 STRASBOURG, France--(BUSINESS WIRE)--Regulatory News…
Data Featured in a Poster Presentation at AASLD Liver Meeting 2017 STRASBOURG, France--(BUSINESS WIRE)-- Regulatory News…
medwireNews: A panel of hepatitis B virus (HBV) experts has issued a consensus statement intended to aid in standardizing the…